Inspire Medical Systems financials
$73.18+4.54%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $200.6M | $204.6M | $269.1M | $224.5M | $217.1M | $201.3M | $239.7M | $203.2M | $195.9M | $164.0M | $192.5M | $153.3M |
| Gross profit | $171.5M | $176.9M | $233.0M | $192.7M | $182.4M | $170.6M | $203.7M | $170.8M | $166.0M | $139.3M | $164.5M | $128.9M |
| Gross margin | 85.5% | 86.5% | 86.6% | 85.8% | 84.0% | 84.7% | 85.0% | 84.1% | 84.8% | 84.9% | 85.4% | 84.1% |
| Operating income | -$514.0K | -$1.1M | $46.1M | $9.6M | -$3.3M | -$1.5M | $31.9M | $14.3M | $5.1M | -$15.2M | $9.3M | -$13.5M |
| Net income | $314.0K | -$11.3M | $136.1M | $9.9M | -$3.6M | $3.0M | $35.2M | $18.5M | $9.8M | -$10.0M | $14.8M | -$8.5M |
| Net margin | 0.2% | −5.5% | 50.6% | 4.4% | −1.7% | 1.5% | 14.7% | 9.1% | 5.0% | −6.1% | 7.7% | −5.6% |
| Diluted EPS | $0.01 | $-0.39 | $4.60 | $0.34 | $-0.12 | $0.10 | $1.12 | $0.60 | $0.32 | $-0.34 | $0.50 | $-0.29 |
| EBITDA | $4.1M | $4.0M | $49.9M | $13.3M | $98.0K | $1.6M | $34.4M | $16.2M | $6.5M | -$14.4M | $9.3M | -$12.7M |
| Operating cash flow | $23.2M | $12.8M | $52.5M | $68.5M | $2.7M | -$6.7M | $69.2M | $52.3M | -$78.0K | $8.9M | $17.3M | $3.6M |
| Free cash flow | $14.1M | $3.1M | $41.8M | $58.1M | -$6.3M | -$15.1M | $62.2M | $44.3M | -$12.5M | -$2.8M | $9.2M | -$3.4M |
| Diluted shares | 28.9M | 28.7M | 29.6M | 29.6M | 29.5M | 30.3M | 31.5M | 30.6M | 30.4M | 29.6M | 29.5M | 29.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $127.8M | $98.9M | $104.8M | $112.8M | $106.9M | $53.9M |
| Short-term investments | $192.9M | $184.9M | $203.5M | $209.7M | $194.0M | $315.3M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $926.0M | $911.4M | $907.3M | $807.7M | $802.2M | $730.8M |
| Total liabilities | $100.4M | $119.0M | $126.2M | $141.3M | $124.4M | $95.1M |
| Shareholders' equity | $825.6M | $792.3M | $781.2M | $666.5M | $677.8M | $635.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology